{"id":16850,"date":"2026-07-24T12:17:11","date_gmt":"2026-07-24T10:17:11","guid":{"rendered":"https:\/\/q-finity.de\/eu-gmp-annex-22\/"},"modified":"2026-10-13T00:05:00","modified_gmt":"2026-10-12T22:05:00","slug":"eu-gmp-annex-22","status":"publish","type":"page","link":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","title":{"rendered":"EU GMP Annex 22"},"content":{"rendered":"\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":16858,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-16850","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.5 (Yoast SEO v28.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Annex 22 (EU GMP): AI Draft and Limits Explained | QFINITY<\/title>\n<meta name=\"description\" content=\"Annex 22 made clear: what the AI draft provides for in GMP, where the boundary for critical applications lies, what the EMA workshop left open, what to do.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Annex 22 (EU GMP): AI Draft and Limits Explained | QFINITY\" \/>\n<meta property=\"og:description\" content=\"Annex 22 made clear: what the AI draft provides for in GMP, where the boundary for critical applications lies, what the EMA workshop left open, what to do.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/\" \/>\n<meta property=\"og:site_name\" content=\"QFINITY\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-12T22:05:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e2.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"EU GMP Annex 22\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/\",\"url\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/\",\"name\":\"Annex 22 (EU GMP): AI Draft and Limits Explained | QFINITY\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/q-finity.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/annex-22-hero-e2.png\",\"datePublished\":\"2026-07-24T10:17:11+00:00\",\"dateModified\":\"2026-10-12T22:05:00+00:00\",\"description\":\"Annex 22 made clear: what the AI draft provides for in GMP, where the boundary for critical applications lies, what the EMA workshop left open, what to do.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#primaryimage\",\"url\":\"https:\\\/\\\/q-finity.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/annex-22-hero-e2.png\",\"contentUrl\":\"https:\\\/\\\/q-finity.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/annex-22-hero-e2.png\",\"width\":1920,\"height\":1071,\"caption\":\"EU GMP Annex 22 - the AI annex to the EU GMP guideline crystallizing out of the consultation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/q-finity.de\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU GMP Annex 22\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/q-finity.de\\\/en\\\/\",\"name\":\"QFINITY\",\"description\":\"Qualit\u00e4tsmanagement &amp; - sicherung\",\"publisher\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/q-finity.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#organization\",\"name\":\"QFINITY\u221e\",\"url\":\"https:\\\/\\\/q-finity.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/mlsqau6zetur.i.optimole.com\\\/cb:frAi.c2d9\\\/w:512\\\/h:512\\\/q:mauto\\\/f:best\\\/https:\\\/\\\/q-finity.de\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/cropped-cropped-signet_PAN_orange.png\",\"contentUrl\":\"https:\\\/\\\/mlsqau6zetur.i.optimole.com\\\/cb:frAi.c2d9\\\/w:512\\\/h:512\\\/q:mauto\\\/f:best\\\/https:\\\/\\\/q-finity.de\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/cropped-cropped-signet_PAN_orange.png\",\"width\":512,\"height\":512,\"caption\":\"QFINITY\u221e\"},\"image\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/q-finity-quality-management\\\/\",\"https:\\\/\\\/www.instagram.com\\\/qfinity_official\\\/\",\"https:\\\/\\\/www.wikidata.org\\\/wiki\\\/Q141257555\"],\"founder\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#founder\"}},{\"@type\":\"FAQPage\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#faq\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"When does Annex 22 take effect?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No date has been set. The consultation ended in October 2025, and the EMA expert workshop took place on 30 June and 1 July 2026. The EMA published the workshop report in early October 2026. After that, a revised draft, finalization and transition periods are expected. Until then the computerized system is validated under Annex 11. Quality risk management under ICH Q9(R1) guides the extent of the evidence.\"}},{\"@type\":\"Question\",\"name\":\"Does Annex 22 apply to LLMs and generative AI?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"In the consultation draft, generative AI and LLMs fall outside the scope of Annex 22, yet the draft is clear about them. Under the draft, they should not be used in critical GMP applications, and the evidence sections apply only to static models. Outside critical applications they may be used, provided a human reviews the outputs. The regulated company is responsible for that use. This exclusion was the central point of criticism in the consultation. According to the workshop report of October 2026, the drafting group has discussed admitting these models under a documented, risk-based control strategy.\"}},{\"@type\":\"Question\",\"name\":\"How does the draft determine what counts as a critical application?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Under the draft, an application is critical when the model has a direct impact on patient safety, product quality or data integrity. In Barcelona, the rapporteur of the drafting group explained the guiding question behind it: what effect would an error have, and would it be detected? Impact and detectability determine criticality. At this stage, the technology used plays no part in this classification. Which model classes the draft admits in critical applications is a separate question.\"}},{\"@type\":\"Question\",\"name\":\"Does Annex 22 replace Annex 11?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. Annex 22 is designed as supplementary guidance to Annex 11. The computerized system is still validated under Annex 11, and the planned Annex 22 is intended to govern the evidence for the embedded model in addition, from intended use to operation.\"}},{\"@type\":\"Question\",\"name\":\"How do the model, the AI system and the AI subsystem relate?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Annex 22 concentrates on the model, that is, on training, testing and the evidence of its fitness for purpose. We take a wider view. An AI system or AI subsystem integrates one or more models and additional functions, such as technical control mechanisms, often called \\\"guardrails\\\" in the debate, into a system component. Performance can then be measured at several levels, so that the suitability of all subcomponents and their interplay can be checked.\"}},{\"@type\":\"Question\",\"name\":\"What roles and personnel requirements does Annex 22 set out?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Section 2.1 of the draft calls for close cooperation among everyone involved, from algorithm selection through training, validation (in the model-development sense) and testing to operation. It names process SMEs, QA, data science, IT and consultants, each with adequate qualifications, defined responsibilities and appropriate access rights. For generative models outside critical applications, qualified personnel carry the responsibility for ensuring the outputs are suitable for the intended use. The cooperation under section 2.1 is also Knowledge Management. ICH Q10 names it, alongside quality risk management, as one of the two enablers of the quality system. That keeps knowledge about models, data and their limits inside the organization. The H\u00b2 Academy, our e-learning program on AI in GxP, builds the qualification this calls for.\"}},{\"@type\":\"Question\",\"name\":\"What can regulated companies do today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Regulated companies can meet the core of the requirements before finalization. An AI inventory, intended use and criticality assessment per application, test metrics, independent test data, monitoring and human oversight can all be implemented under the current Annex 11. ICH Q9(R1) guides how far the evidence has to go. Since July 2025, the methodology for AI-enabled systems has had a home of its own, the ISPE GAMP Guide: Artificial Intelligence. The draft makes much of this explicit for AI models.\"}}],\"isPartOf\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#founder\",\"name\":\"Oliver Herrmann\",\"jobTitle\":\"Founder & CEO\",\"url\":\"https:\\\/\\\/q-finity.de\\\/en\\\/\",\"worksFor\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#organization\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/olherrmann\\\/\",\"https:\\\/\\\/virtual.ispe.org\\\/b\\\/sp\\\/oliver-herrmann-4399\",\"https:\\\/\\\/www.wikidata.org\\\/wiki\\\/Q141257562\"],\"knowsAbout\":[\"GxP-Compliance\",\"Computer System Validation\",\"Computer Software Assurance\",\"Data Integrity\",\"ALCOA++\",\"AI Governance\",\"GAMP 5\"],\"image\":\"https:\\\/\\\/q-finity.de\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/oliver-herrmann-qfinity-ceo-scaled.jpg\",\"description\":\"Founder and CEO of QFINITY, GAMP Europe Chair, qualified GAMP 5 and GAMP Data Integrity trainer, GQMA auditor and international speaker. Co-author of several ISPE GAMP guides, including the GAMP 5 Guide (2nd Edition).\",\"memberOf\":{\"@type\":\"Organization\",\"name\":\"International Society for Pharmaceutical Engineering (ISPE)\",\"url\":\"https:\\\/\\\/ispe.org\"},\"hasCredential\":[{\"@type\":\"EducationalOccupationalCredential\",\"credentialCategory\":\"degree\",\"name\":\"Graduate Computer Scientist (Dipl.-Inf.)\"},{\"@type\":\"EducationalOccupationalCredential\",\"credentialCategory\":\"certification\",\"name\":\"Microsoft Certified Systems Engineer (MCSE)\"},{\"@type\":\"EducationalOccupationalCredential\",\"credentialCategory\":\"certification\",\"name\":\"SAFe (Scaled Agile Framework)\"}]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Annex 22 (EU GMP): AI Draft and Limits Explained | QFINITY","description":"Annex 22 made clear: what the AI draft provides for in GMP, where the boundary for critical applications lies, what the EMA workshop left open, what to do.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","og_locale":"en_US","og_type":"article","og_title":"Annex 22 (EU GMP): AI Draft and Limits Explained | QFINITY","og_description":"Annex 22 made clear: what the AI draft provides for in GMP, where the boundary for critical applications lies, what the EMA workshop left open, what to do.","og_url":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","og_site_name":"QFINITY","article_modified_time":"2026-10-12T22:05:00+00:00","og_image":[{"url":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e2.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"EU GMP Annex 22","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","url":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","name":"Annex 22 (EU GMP): AI Draft and Limits Explained | QFINITY","isPartOf":{"@id":"https:\/\/q-finity.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#primaryimage"},"image":{"@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#primaryimage"},"thumbnailUrl":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e2.png","datePublished":"2026-07-24T10:17:11+00:00","dateModified":"2026-10-12T22:05:00+00:00","description":"Annex 22 made clear: what the AI draft provides for in GMP, where the boundary for critical applications lies, what the EMA workshop left open, what to do.","breadcrumb":{"@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#primaryimage","url":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e2.png","contentUrl":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e2.png","width":1920,"height":1071,"caption":"EU GMP Annex 22 - the AI annex to the EU GMP guideline crystallizing out of the consultation"},{"@type":"BreadcrumbList","@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/q-finity.de\/en\/home\/"},{"@type":"ListItem","position":2,"name":"EU GMP Annex 22"}]},{"@type":"WebSite","@id":"https:\/\/q-finity.de\/en\/#website","url":"https:\/\/q-finity.de\/en\/","name":"QFINITY","description":"Qualit\u00e4tsmanagement &amp; - sicherung","publisher":{"@id":"https:\/\/q-finity.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/q-finity.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/q-finity.de\/en\/#organization","name":"QFINITY\u221e","url":"https:\/\/q-finity.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/q-finity.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:frAi.c2d9\/w:512\/h:512\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2021\/03\/cropped-cropped-signet_PAN_orange.png","contentUrl":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:frAi.c2d9\/w:512\/h:512\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2021\/03\/cropped-cropped-signet_PAN_orange.png","width":512,"height":512,"caption":"QFINITY\u221e"},"image":{"@id":"https:\/\/q-finity.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/q-finity-quality-management\/","https:\/\/www.instagram.com\/qfinity_official\/","https:\/\/www.wikidata.org\/wiki\/Q141257555"],"founder":{"@id":"https:\/\/q-finity.de\/en\/#founder"}},{"@type":"FAQPage","@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#faq","mainEntity":[{"@type":"Question","name":"When does Annex 22 take effect?","acceptedAnswer":{"@type":"Answer","text":"No date has been set. The consultation ended in October 2025, and the EMA expert workshop took place on 30 June and 1 July 2026. The EMA published the workshop report in early October 2026. After that, a revised draft, finalization and transition periods are expected. Until then the computerized system is validated under Annex 11. Quality risk management under ICH Q9(R1) guides the extent of the evidence."}},{"@type":"Question","name":"Does Annex 22 apply to LLMs and generative AI?","acceptedAnswer":{"@type":"Answer","text":"In the consultation draft, generative AI and LLMs fall outside the scope of Annex 22, yet the draft is clear about them. Under the draft, they should not be used in critical GMP applications, and the evidence sections apply only to static models. Outside critical applications they may be used, provided a human reviews the outputs. The regulated company is responsible for that use. This exclusion was the central point of criticism in the consultation. According to the workshop report of October 2026, the drafting group has discussed admitting these models under a documented, risk-based control strategy."}},{"@type":"Question","name":"How does the draft determine what counts as a critical application?","acceptedAnswer":{"@type":"Answer","text":"Under the draft, an application is critical when the model has a direct impact on patient safety, product quality or data integrity. In Barcelona, the rapporteur of the drafting group explained the guiding question behind it: what effect would an error have, and would it be detected? Impact and detectability determine criticality. At this stage, the technology used plays no part in this classification. Which model classes the draft admits in critical applications is a separate question."}},{"@type":"Question","name":"Does Annex 22 replace Annex 11?","acceptedAnswer":{"@type":"Answer","text":"No. Annex 22 is designed as supplementary guidance to Annex 11. The computerized system is still validated under Annex 11, and the planned Annex 22 is intended to govern the evidence for the embedded model in addition, from intended use to operation."}},{"@type":"Question","name":"How do the model, the AI system and the AI subsystem relate?","acceptedAnswer":{"@type":"Answer","text":"Annex 22 concentrates on the model, that is, on training, testing and the evidence of its fitness for purpose. We take a wider view. An AI system or AI subsystem integrates one or more models and additional functions, such as technical control mechanisms, often called \"guardrails\" in the debate, into a system component. Performance can then be measured at several levels, so that the suitability of all subcomponents and their interplay can be checked."}},{"@type":"Question","name":"What roles and personnel requirements does Annex 22 set out?","acceptedAnswer":{"@type":"Answer","text":"Section 2.1 of the draft calls for close cooperation among everyone involved, from algorithm selection through training, validation (in the model-development sense) and testing to operation. It names process SMEs, QA, data science, IT and consultants, each with adequate qualifications, defined responsibilities and appropriate access rights. For generative models outside critical applications, qualified personnel carry the responsibility for ensuring the outputs are suitable for the intended use. The cooperation under section 2.1 is also Knowledge Management. ICH Q10 names it, alongside quality risk management, as one of the two enablers of the quality system. That keeps knowledge about models, data and their limits inside the organization. The H\u00b2 Academy, our e-learning program on AI in GxP, builds the qualification this calls for."}},{"@type":"Question","name":"What can regulated companies do today?","acceptedAnswer":{"@type":"Answer","text":"Regulated companies can meet the core of the requirements before finalization. An AI inventory, intended use and criticality assessment per application, test metrics, independent test data, monitoring and human oversight can all be implemented under the current Annex 11. ICH Q9(R1) guides how far the evidence has to go. Since July 2025, the methodology for AI-enabled systems has had a home of its own, the ISPE GAMP Guide: Artificial Intelligence. The draft makes much of this explicit for AI models."}}],"isPartOf":{"@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/"}},{"@type":"Person","@id":"https:\/\/q-finity.de\/en\/#founder","name":"Oliver Herrmann","jobTitle":"Founder & CEO","url":"https:\/\/q-finity.de\/en\/","worksFor":{"@id":"https:\/\/q-finity.de\/en\/#organization"},"sameAs":["https:\/\/www.linkedin.com\/in\/olherrmann\/","https:\/\/virtual.ispe.org\/b\/sp\/oliver-herrmann-4399","https:\/\/www.wikidata.org\/wiki\/Q141257562"],"knowsAbout":["GxP-Compliance","Computer System Validation","Computer Software Assurance","Data Integrity","ALCOA++","AI Governance","GAMP 5"],"image":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/06\/oliver-herrmann-qfinity-ceo-scaled.jpg","description":"Founder and CEO of QFINITY, GAMP Europe Chair, qualified GAMP 5 and GAMP Data Integrity trainer, GQMA auditor and international speaker. Co-author of several ISPE GAMP guides, including the GAMP 5 Guide (2nd Edition).","memberOf":{"@type":"Organization","name":"International Society for Pharmaceutical Engineering (ISPE)","url":"https:\/\/ispe.org"},"hasCredential":[{"@type":"EducationalOccupationalCredential","credentialCategory":"degree","name":"Graduate Computer Scientist (Dipl.-Inf.)"},{"@type":"EducationalOccupationalCredential","credentialCategory":"certification","name":"Microsoft Certified Systems Engineer (MCSE)"},{"@type":"EducationalOccupationalCredential","credentialCategory":"certification","name":"SAFe (Scaled Agile Framework)"}]}]}},"_links":{"self":[{"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/pages\/16850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/comments?post=16850"}],"version-history":[{"count":5,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/pages\/16850\/revisions"}],"predecessor-version":[{"id":17106,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/pages\/16850\/revisions\/17106"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/media\/16858"}],"wp:attachment":[{"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/media?parent=16850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}